Related Experiment Videos
Do we need better prognostic factors in nodal-negative breast cancer? Contra
1Department of Obstetrics and Gynaecology, Johann Wolfgang Goethe-University, Frankfurt, Germany. m.kaufmann@em.uni-frankfurt.de
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers.
Journal of cancer research and clinical oncology·2022
Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis.
Journal of cancer research and clinical oncology·2017
Significance of Ovarian Function Suppression in Endocrine Therapy for Breast Cancer in Pre-Menopausal Women.
Geburtshilfe und Frauenheilkunde·2016
The Right Treatment for the Right Patient - Personalised Treatment of Breast Cancer.
Geburtshilfe und Frauenheilkunde·2015
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation].
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2015
Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.
European journal of cancer (Oxford, England : 1990)·2026
Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?
European journal of cancer (Oxford, England : 1990)·2026
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026
miR-27b-5p targets RAB27A to regulate exosome secretion and migration of pancreatic cancer cells.
Translational cancer research·2026
How cholecystectomy and gastrectomy contribute to pancreatic cancer development: a review.
Annals of medicine and surgery (2012)·2026
Development of m6A-related prognostic models for survival in lung squamous cell carcinoma with different PD-L1 expression levels.
Translational cancer research·2026